Medscape December 11, 2024
Miriam E. Tucker

The American Diabetes Association (ADA)’s Standards of Care — 2025 offer new guidance on broader use of continuous glucose monitoring (CGM), use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) beyond weight loss, management of metabolic dysfunction-associated liver disease (MAFLD), plus a strong endorsement for drinking water and much more.

The Standards of Care — 2025 were published December 9 as a supplement to Diabetes Care. The standards “incorporate the latest information from clinical trial data and knowledge of diabetes management into a comprehensive guidelines document that will assist physicians in managing patients with diabetes in their practices,” Mandeep Bajaj, MBBS, ADA’s President, Medicine & Science, told Medscape Medical News.

In an interview, Bajaj highlighted some of the most important...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Patient / Consumer, Pharma / Biotech, Provider, Technology, Wearables
Joining Forces: 2024’s Hospice Investment, Consolidation Trends
U.S. health care spending hits $4.9 trillion in 2023
Florida health system eyes 2025 as 'year of innovation' after Epic go-live
Congress proposes temporary 2.5% physician pay bump in new healthcare package
Johns Hopkins Medicine inks AI deal with Abridge

Share This Article